Niels Von Wardenburg
Berlin, BE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Engineered Bi-Specific AChR CAAR T Cells for Selective Elimination of Myasthenia Gravis B Cells.
Journal: Research square
Published: March 27, 2026
Engineered Bi-Specific AChR CAAR T Cells for Selective Elimination of Myasthenia Gravis B Cells.
Journal: Research square
Published: March 27, 2026
Bispecific chimeric autoantibody receptor T cells eliminate acetylcholine receptor-specific B cells in myasthenia gravis models.
Journal: Nature communications
Published: March 11, 2026
Chimeric autoantibody receptor T cells deplete NMDA receptor-specific B cells.
Journal: Cell
Published: April 19, 2023
SARS-CoV-2 Beta variant infection elicits potent lineage-specific and cross-reactive antibodies.
Journal: Science (New York, N.Y.)
Published: January 25, 2022
A SARS-CoV-2 neutralizing antibody protects from lung pathology in a COVID-19 hamster model.
Journal: bioRxiv : the preprint server for biology
Published: August 21, 2020
Glycine Receptor Autoantibodies Impair Receptor Function and Induce Motor Dysfunction.
Journal: Annals of neurology
Published: March 17, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026